Ann: Appendix 4C - quarterly, page-30

Well Slick, that was a stab in the dark. You missed the target. I was hoping for a number . Mind you, I didn’t expect one.

I’ve a very small holding, so I’m here for the long hall with fingers X’d. It would be nice if everyone else was.

The science and team behind this justifies a very significant increase in SP already, however the market sleeps.

I wouldn’t dare suggest a number at this stage as I’m new to this. Others on the list have suggested anywhere from 10c to $1 to $10. Which is the more likely given successful trials?

That said, our number 1 shareholder would be crazy to sell out too early. Why sell the goose that "may" lay the golden egg. Leslie is on record as saying they want to turn this company into a formidable player in the biotech field.

I’ve been reading this list for quite some time now, and really appreciate all the input.